(ITOS) Iteos Therapeutics - Performance -27.4% in 12m
ITOS performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-61.55%
#89 in Peer-Group
Rel. Strength
17.63%
#6322 in Stock-Universe
Total Return 12m
-27.36%
#94 in Peer-Group
Total Return 5y
-46.56%
#58 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 12.6 |
| High / Low | USD |
|---|---|
| 52 Week High | 17.97 USD |
| 52 Week Low | 5.04 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 85.06 |
| Buy/Sell Signal +-5 | 0.71 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ITOS (-27.4%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ITOS vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ITOS
| Total Return (including Dividends) | ITOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.20% | 3.36% | 5.25% |
| 3 Months | 88.87% | 15.73% | 24.13% |
| 12 Months | -27.36% | -7.02% | 14.15% |
| 5 Years | -46.56% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | ITOS | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -29.6% | 4.4% | 81% |
| 3 Months | 89.2% | 78.8% | 96.9% |
| 12 Months | -61.3% | -85.8% | 44.9% |
| 5 Years | -87.3% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th51.00 | -3.44% | -5.17% |
| 3 Month | %th91.50 | 63.20% | 52.15% |
| 12 Month | %th53.50 | -21.88% | -36.37% |
| 5 Years | %th72.00 | -29.92% | -74.47% |
FAQs
Does Iteos Therapeutics (ITOS) outperform the market?
No,
over the last 12 months ITOS made -27.36%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months ITOS made 88.87%, while XBI made 15.73%.
Performance Comparison ITOS vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ITOS vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.6% | -5.5% | 20.6% | -42% |
| US NASDAQ 100 | QQQ | 0.8% | -5.5% | 20% | -40% |
| German DAX 40 | DAX | 2.8% | 1.2% | 8.5% | -56% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.8% | -3.4% | 17.2% | -47% |
| Hongkong Hang Seng | HSI | 1% | -6.3% | 1.2% | -66% |
| India NIFTY 50 | INDA | 2.4% | -3.7% | 20.3% | -27% |
| Brasil Bovespa | EWZ | -1.9% | -9% | -4.4% | -37% |
ITOS vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2% | -6.1% | 16.5% | -52% |
| Consumer Discretionary | XLY | 1.1% | -3.4% | 28.3% | -45% |
| Consumer Staples | XLP | 0.3% | -0.8% | 19% | -36% |
| Energy | XLE | 0.3% | -7.3% | 24.8% | -27% |
| Financial | XLF | -0.1% | -5.3% | 15.7% | -57% |
| Health Care | XLV | 1.1% | -2.3% | 28% | -23% |
| Industrial | XLI | 0.5% | -4.4% | 12.8% | -52% |
| Materials | XLB | -1.7% | -4.5% | 16.1% | -33% |
| Real Estate | XLRE | 0.7% | -1.2% | 20.9% | -40% |
| Technology | XLK | -0.2% | -8.9% | 18.3% | -38% |
| Utilities | XLU | 1.7% | -2% | 17.4% | -50% |
| Aerospace & Defense | XAR | 2.7% | -7.3% | 2.1% | -77% |
| Biotech | XBI | -0.4% | -3.6% | 33.9% | -20% |
| Homebuilder | XHB | -1.9% | -7.2% | 27.8% | -33% |
| Retail | XRT | -1.9% | -5.2% | 25% | -39% |
ITOS vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -0.3% | -8.64% | 29.0% | -20% |
| Natural Gas | UNG | 10.1% | 9.6% | 37.4% | -25% |
| Gold | GLD | 0.3% | 1% | 0% | -66% |
| Silver | SLV | -0.4% | -7.1% | 3.3% | -45% |
| Copper | CPER | 1.6% | -4.8% | 3.6% | -38% |
ITOS vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 2.4% | -1.3% | 24.1% | -25% |
| iShares High Yield Corp. Bond | HYG | 1.8% | -1.8% | 21.7% | -37% |